Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Gut microbiota play an important part in the pathogenesis of mucosal inflammation, such as inflammatory bowel disease (IBD). However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in the maintenance of immune homeostasis in the gut is evolving only slowly. Here, we evaluated the role of gut microbiota and their secreting extracellular vesicles (EV) in the development of mucosal inflammation in the gut. Experimental IBD model was established by oral application of dextran sulfate sodium (DSS) to C57BL/6 mice. The composition of gut microbiota and bacteria-derived EV in stools was evaluated by metagenome sequencing using bacterial common primer of 16S rDNA. Metagenomics in the IBD mouse model showed that the change in stool EV composition was more drastic, compared to the change of bacterial composition. Oral DSS application decreased the composition of EV from Akkermansia muciniphila and Bacteroides acidifaciens in stools, whereas increased EV from TM7 phylum, especially from species DQ777900_s and AJ400239_s. In vitro pretreatment of A. muciniphila-derived EV ameliorated the production of a pro-inflammatory cytokine IL-6 from colon epithelial cells induced by Escherichia coli EV. Additionally, oral application of A. muciniphila EV also protected DSS-induced IBD phenotypes, such as body weight loss, colon length, and inflammatory cell infiltration of colon wall. Our data provides insight into the role of gut microbiota-derived EV in regulation of intestinal immunity and homeostasis, and A. muciniphila-derived EV have protective effects in the development of DSS-induced colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also revealed the protective effects of A. muciniphila-derived extracellular vesicles in DSS-induced colitis.28”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364 · cited 1×
“commensal bacteria in genetically susceptible individuals [3].”
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“As some bacteria are being investigated for its protective qualities in regards to the human immunity, other microbiota have generated interest in their pathogenic features that link them to certain diseases [27].”
BackgroundCommensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“muciniphila (ATCC BAA-835) was cultured in an anaerobic condition that was maintained to 90% N2 and 10% CO2, the method previously described [20].”
BackgroundMethodThe immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 1×
“human intestines; however, in CD and UC, there is a large reduction in the number of these bacteria [21].”
BackgroundRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing
Andersson, A. F., Lindberg, M., Jakobsson, H., Bäckhed, F., Nyrén, P., & Engstrand, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002836 · Cited by 1,038
Cited by
Items 301–400 of 542
Cheng, Z., Zhao, L., Dhall, D., Ruegger, P. M., Borneman, J., & Frykman, P. K. (2018) · Frontiers in Surgery · doi:10.3389/fsurg.2018.00030 · Cited by 23
“While Akkermansia has been suggested to have anti-inflammatory properties (19), it has been noted in mouse models to be markedly increased after dextran sulfate sodium (DSS) treatment to induce colitis in multiple studies (20–23) and not in others (24).”
BackgroundYang, J., McDowell, A., Kim, E. K., Seo, H., Yum, K., Lee, W. H., Jee, Y., & Kim, Y. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0288-1 · Cited by 28
Zang, R., Zhou, R., Li, Y., Wu, H., Lü, L., & Xu, H. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03520-w · Cited by 22
Zhao, S., Xiang, J., Abedin, M., Wang, J., Zhang, Z., Zhang, Z., Wu, H., & Xiao, J. (2025) · Microorganisms · doi:10.3390/microorganisms13020464 · Cited by 26
Duarte-Silva, E. P., Oriá, A. C., Mendonça, I. P., de Melo, M. G., de Paiva, I. H. R., Maes, M. H. J., Joca, S. R. L., & Peixoto, C. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104582 · Cited by 22
Mofrad, L. Z., Fateh, A., Sotoodehnejadnematalahi, F., Shamasbi, D. N., & Siadat, S. D. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10058-6 · Cited by 22
“Moreover, as it contains all the advantageous and functional metabolites of the bacterial fora, the administration of bacterial cell-free supernatant is advised as a replacement for alive bacteria to prevent inflammatory and antibiotic resistance adverse effects [30].”
Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma
Jingushi, K., Kawashima, A., Tanikawa, S., Saito, T., Yamamoto, A., Uemura, T., Sassi, N., Ishizuya, Y., Yamamoto, Y., Kato, T., et al. (2024) · Cancer Science · doi:10.1111/cas.16202 · Cited by 23
“17 Information on the characteristic blood EVs-derived bacterial flora has been reported in patients with urothelial carcinoma 18 and in those with RCC. 19 In renal cancer, the blood BTS index (Bacteroidia, TM7-1, and Sphingomonadales) reflects cancer diagnosis, nivolumab drug sensitivity, and the…”
BackgroundRetinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice
Xu, Y., Ding, C., Qian, C.-L., Qi, Z., & Wang, W. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2186-9 · Cited by 23
Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers
Su, K.-Y., Kok, J.-Y. K., Chua, Y. W., Ong, S.-D., Ser, H. L., Pusparajah, P., Saw, P. S., Goh, B. H., & Lee, W.-L. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2166403 · Cited by 21
“able regions to differentiate from the host-derived eukaryotic EVs as well as for quantification, identification, and classification of bacteria within complex samples [8].”
BackgroundChen, L., Ou, Q., & Kou, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121830 · Cited by 20
Lee, H.-K., Kim, N.-E., Shin, C. M., Oh, T. J., Yoon, H., Park, Y. S., Kim, N., Won, S., & Lee, D. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-53837-z · Cited by 27
“The anti-inflammatory effects of Akkermansia -derived EVs have been previously reported in various studies 22–24 .”
BackgroundProtein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner
Spalinger, M. R., Schmidt, T., Schwarzfischer, M., Hering, L., Atrott, K., Lang, S., Gottier, C., Geirnaert, A., Lacroix, C., Dai, X., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123263 · Cited by 23
“The role of Akkermansia in intestinal health is controversial, and it is unclear whether its biological roles in the human and murine gut are equivalent: while some reports showed that Akkermansia might reduce inflammation (33), a recent study showed that presence of Akkermansia promotes colitis in IL-10–/– mice (34).”
BackgroundHarnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
Karaman, İ., Pathak, A., Bayık, D., & Watson, D. C. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i1.657 · Cited by 20
“For instance, Akkermansia muciniphila bEVs demonstrated protective effects on the dextran sulfate sodium (DSS)-induced model of inflammatory bowel disease (IBD) [72], suggesting bEVs as a potential mediator of commensal microbe-host interaction in this disease.”
BackgroundNie, S., Zhang, Z., Ji, Y., Ding, Q., Gong, J., Xiao, F., Chen, L., Tian, D., Liu, M., & Luo, Z. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2379633 · Cited by 25
Olivo-Martínez, Y., Martínez-Ruiz, S., Cordero, C., Badía, J., & Baldomà, L. (2024) · Nutrients · doi:10.3390/nu16162719 · Cited by 21
“…gut commensals in ameliorating IBD through different mechanisms, mainly involving the reinforcement of the epithelial barrier and anti-inflammatory effects [30,64–66], translation of probiotic/microbiota EVs to human health as a postbiotic strategy requires deep knowledge of the action mechanisms.”
BackgroundLü, J., Wang, Y., Wu, J., Duan, Y., Zhang, H., & Du, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1503474 · Cited by 30
Engineered Bacterial Extracellular Vesicles: Developments, Challenges, and Opportunities
Li, Q., Chen, X., Xie, J., & Nie, S. (2025) · Engineering · doi:10.1016/j.eng.2025.06.042 · Cited by 23
Aldriwesh, M. G., Alotibi, R. S., Alqurainy, N., Alrabiah, S., Arafah, A. M., Alghoribi, M. F., & Ajina, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2607076 · Cited by 24
Outer membrane vesicles as versatile tools for therapeutic approaches
Zingl, F. G., Leitner, D. R., Thapa, H. B., & Schild, S. (2021) · microLife · doi:10.1093/femsml/uqab006 · Cited by 22
Wang, Y., Li, J., Ma, C., Jiang, S., Li, C., Zhang, L., & Zhang, J. (2021) · Food & Function · doi:10.1039/d1fo01388b · Cited by 22
Gu, Z., Meng, S., Wang, Y., Lyu, B., Li, P., & Shang, N. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2039897 · Cited by 20
Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
Wang, L., Shao, L., Chen, M., Wang, L., Zhang, W., Tan, F., & Huang, W. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00701-9 · Cited by 24
An exploratory study on the effect of daily fruits and vegetable juice on human gut microbiota
Choi, Y. J., Lee, D. H., Kim, H. S., & Kim, Y.-K. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0372-7 · Cited by 22
Casein-fed mice showed faster recovery from DSS-induced colitis than chicken-protein-fed mice
Yu, L., Zhao, D., Nian, Y., & Li, C. (2021) · Food & Function · doi:10.1039/d1fo00659b · Cited by 22
Xiao, M., Huang, M., Huan, W., Dong, J., Xiao, J., Wu, J., Wang, D., & Song, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4472751 · Cited by 19
RetractedPompili, S., Vetuschi, A., Sferra, R., & Cappariello, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933675 · Cited by 19
Update on gut microbiota in gastrointestinal diseases
Nishida, A., Nishino, K., Ohno, M., Sakai, K., Owaki, Y., Noda, Y., & Imaeda, H. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i22.7653 · Cited by 25
Thapa, H. B., Kohl, P., Zingl, F. G., Fleischhacker, D., Wolinski, H., Kufer, T. A., & Schild, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01115-23 · Cited by 23
The role of fungi in C. difficile infection: An underappreciated transkingdom interaction
Stewart, D., Romo, J. A., Lamendella, R., & Kumamoto, C. A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.04.007 · Cited by 21
Liu, L., Wu, J., Gao, J., & Lu, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000893 · Cited by 18
Gut Microbiome Profiles and Associated Metabolic Pathways in HIV-Infected Treatment-Naïve Patients
do Nascimento, W. M., Machiavelli, A., Ferreira, L. G. E., Silveira, L. C., de Azevedo, S. S. D., Bello, G., Smith, D. P., Mezzari, M. P., Petrosino, J. F., Duarte, R. T. D., et al. (2021) · Cells · doi:10.3390/cells10020385 · Cited by 21
Frühbeck, G., Mentxaka, A., Ahechu, P., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Rodríguez, A., Unamuno, X., Cienfuegos, J. A., Casado, M., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s335882 · Cited by 19
“muciniphila and its derived components has demonstrated to improve the metabolic profile and diet-induced obesity in terms of body weight gain and body composition in both animal models and humans,(18,19) as well as the symptoms of DSS-induced colitis in mice.(55,56) Lee et al demonstrated that the administration of L…”
BackgroundKrela‐Kaźmierczak, I., Zakerska‐Banaszak, O., Skrzypczak-Zielińska, M., Łykowska‐Szuber, L., Szymczak‐Tomczak, A., Zawada, A. E., Rychter, A. M., Ratajczak, A. E., Skoracka, K., Skrzypczak, D., et al. (2022) · Nutrients · doi:10.3390/nu14122520 · Cited by 19
“Its deficiency may result from reduced levels of mucin in patients with UC, which constitute an energy source for these bacteria [136].”
BackgroundDeficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis
Feng, Q., Li, Y., Zhang, H., Wang, Z., Nie, X., Yao, D., Lu, H., Chen, W., & Wang, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.018 · Cited by 19
Choi, H., Mun, D., Ryu, S., Kwak, M., Kim, B., Park, D., Oh, S., & Kim, Y. (2022) · Journal of Animal Science and Technology · doi:10.5187/jast.2022.e124 · Cited by 18
Ajam-Hosseini, M., Akhoondi, F., Parvini, F., & Fahimi, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1305510 · Cited by 23
Wang, R., Deng, Y., Deng, Q., Sun, D., Fang, Z., Sun, L., Wang, Y., & Gooneratne, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00073 · Cited by 21
Kim, S., Kang, S. A., Kim, Y., Yu, H. S., Cho, K., & Roh, H. (2020) · Stem Cells International · doi:10.1155/2020/5684250 · Cited by 18
Zubair, M., Abouelnazar, F. A., Dawood, A. S., Pan, J., Zheng, X., Chen, T., Liu, P., Mao, F., Yan, Y., & Chu, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1481496 · Cited by 18
Bacterial membrane vesicles in inflammatory bowel disease
Shen, Q., Xu, B., Wang, C., Xiao, Y., & Jin, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120803 · Cited by 18
Zhang, F., Qi, N., Zeng, Y., Bao, M., Chen, Y., Liao, J., Wei, L., Cao, D., Huang, S., Luo, Q., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.557342 · Cited by 20
Gut microbiota-derived extracellular vesicles form a distinct entity from gut microbiota
Kaisanlahti, A., Turunen, J., Hekkala, J., Mishra, S., Salmi, S., Amatya, S. B., Paalanne, N., Krüger, J., Portaankorva, A. M., Koivunen, J. P., et al. (2025) · mSystems · doi:10.1128/msystems.00311-25 · Cited by 20
“Several studies have investigated gut microbiota-derived EVs while exploring shifts in gut microbiota composition related to changes caused by clinical conditions (14, 16–22), probiotic use (23, 24), and dietary factors (25).”
Wang, X., Li, A., Jing, H., Zhang, X., Dong, X., Song, Z., Wu, N., & Zheng, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653472 · Cited by 18
Novel opportunities for the exploitation of host–microbiome interactions in the intestine
Claes, I. J. J., Garcia, C. V., & Lebeer, S. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.008 · Cited by 17
“shown to improve dextran sulfate sodium-induced colitis in mice [24].”
BackgroundDysbiosis Triggers ACF Development in Genetically Predisposed Subjects
Santis, S. D., Liso, M., Vacca, M., Verna, G., Cavalcanti, E., Coletta, S., Calabrese, F. M., Eri, R. D., Lippolis, A., Armentano, R., et al. (2021) · Cancers · doi:10.3390/cancers13020283 · Cited by 17
Acute high‐dose titanium dioxide nanoparticle exposure alters gastrointestinal homeostasis in mice
Kurtz, C. C., Mitchell, S., Nielsen, K., Crawford, K. D., & Mueller‐Spitz, S. R. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.3991 · Cited by 16
“Indeed, signals produced by these microbes have been shown to alter immune responses in the host (Alard et al., 2016; Kang et al., 2013).”
BackgroundZhu, S., Xu, W., Chen, Z., Lei, X., Guan, F., & Ge, J. P. (2025) · Phytotherapy Research · doi:10.1002/ptr.8528 · Cited by 16
Alikhani, H. K., Shokoohian, B., Rezasoltani, S., Hossein‐Khannazer, N., Yadegar, A., Hassan, M., & Vosough, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.785856 · Cited by 16
Sater, A. H. A., Bouferraa, Y., Amhaz, G., Haibe, Y., Lakkiss, A. E., & Shamseddine, A. I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.804983 · Cited by 17
“On the other hand, BEV originating from commensal bacteria may induce immunologic tolerance, hence provide protection from severe infections (107, 108).”
BackgroundGastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases
Petersen, A. M. (2022) · Apmis · doi:10.1111/apm.13256 · Cited by 20
Rodriguez, C., Martín‐Reyes, F., Taminiau, B., Ho‐Plagaro, A., Camargo, R., Fernández-García, F., Pinazo-Bandera, J. M., Toro-Ortiz, J. P., Gonzalo, M., Gomez, C. L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054971 · Cited by 15
Extracellular vesicle miRNAs as key mediators in diet-gut microbiome-host interplay
Dong, X., Liu, Y., Yang, X., & Li, T. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.05.005 · Cited by 19
Akkermansia muciniphila improves chronic colitis‐induced enteric neuroinflammation in mice
Yilmaz, O., Okullu, S. Ö., Catakci, M., Elmas, M. A., Pinheiro, Y. V., Arbak, S., Demir, İ. E., Schaefer, K. H., & Kolgazi, M. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14745 · Cited by 17
Tan, D. S. Y., Akelew, Y., Snelson, M., Nguyen, J., & O’Sullivan, K. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094817 · Cited by 18
“Gut bacterium Akkermansia muciniphila -derived EVs were shown to regulate mucosal inflammation by inhibiting the production of IL-6 from colon epithelial cells in an IBD mouse model [193].”
BackgroundNovel administration strategies for tissue-specific delivery of extracellular vesicles
Deng, J., Li, Q., & Wang, F. (2024) · Extracellular Vesicle · doi:10.1016/j.vesic.2024.100057 · Cited by 17
Parodi, E. L., Novi, M., Bottino, P., Porta, E. L., Merlotti, G., Castello, L. M., Gotta, F., Rocchetti, A., & Quaglia, M. (2025) · Microorganisms · doi:10.3390/microorganisms13020445 · Cited by 21
“Akkermansia muciniphila -derived EVs were shown to inhibit the production of IL-6 from colon epithelial cells and reduce mucosal inflammation in an IBD mouse model [122], and Lactobacillus-derived EVs have been proposed as a therapy for IBD and other AIDs [123].”
Lipinski, S., & Tiemann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073374 · Cited by 16
“In a mouse model of intestinal inflammation, BEVs derived from Akkermansia muciniphila reduced colonic inflammation by lowering levels of inflammatory cytokines and strengthening intestinal barrier function [70,71].”
BackgroundLiang, Y., Wei, X., Ren, R., Zhang, X., Tang, X., Yang, J., Wei, X., Huang, R., Hardiman, G., Sun, Y., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054844 · Cited by 15
The impact of chemerin or chemokine-like receptor 1 loss on the mouse gut microbiome
Dranse, H. J., Zheng, A., Comeau, A., Langille, M. G. I., Zabel, B. A., & Sinal, C. J. (2018) · PeerJ · doi:10.7717/peerj.5494 · Cited by 15
“, 2010) and administration of Akkermansia has been shown to protect against the progression of DSS-induced colitis (Kang et al., 2013).”
BackgroundQin, L.-N., Yu, Y., Ma, L., & Yu, R. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100216 · Cited by 14
“The BEVs of Akkermansia muciniphila mediate immune regulation of the colon and intestinal barrier functions (Kang et al., 2013).”
Wang, Y., Zhang, Y., Song, S., Chen, J., Guo, H., & Lin, Y. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2603666 · Cited by 26
Physiological benefits of Akkermansia muciniphila under high-altitude hypoxia
Mishra, K. P., & Bakshi, J. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12305-2 · Cited by 15
Green tea extract prevents CPT-11-induced diarrhea by regulating the gut microbiota
Kon, R., Ikarashi, N., Yamaguchi, A., Teshima, Y., Yamaguchi, T., Miyaoka, K., Fukuda, M., Noguchi, H., Tomimoto, R., Sakai, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33731-w · Cited by 17
Extracellular Vesicles and Infection: From Hijacked Machinery to Therapeutic Tools
Gonçalves, D., Pinto, S. N., & Fernandes, F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061738 · Cited by 18
“In contrast, BEVs isolated from the gut bacterium Akkermansia muciniphila (commensal bacteria) were shown the ability to down-regulate the production of IL-6 from colon epithelial cells, thus possibly conferring protection during colitis [147].”
BackgroundXue, Y., Huang, X., Ou, Z., Wu, Y., Li, Q., Huang, X., Wen, M., Yang, Y., Situ, B., & Zheng, L. (2023) · Journal of Visualized Experiments · doi:10.3791/65574 · Cited by 19
Xu, C., Ghali, S., Wang, J., Shih, D. Q., ORTIZ, C. W., Mussatto, C. C., Lee, E. C., Tran, D., Jacobs, J. P., Lagishetty, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16753-z · Cited by 16
Korean Traditional Medicine (Jakyakgamcho-tang) Ameliorates Colitis by Regulating Gut Microbiota
Seo, S.-H., Unno, T., Park, S., Kim, E., Lee, Y., Na, C.-S., & Son, H.-S. (2019) · Metabolites · doi:10.3390/metabo9100226 · Cited by 15
“[47], extracellular vesicles from Akkermansia muciniphila can prevent DSS-induced colitis.”
BackgroundMosby, C. A., Edelmann, M. J., & Jones, M. K. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04691-22 · Cited by 14
Das Darmmikrobiom bei der Parkinson-Krankheit
Bedarf, J. R., Hildebrand, F., Goeser, F., Bork, P., & Wüllner, U. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0601-6 · Cited by 27
Castaño, C., Novials, A., & Párrizas, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032071 · Cited by 17
Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto, R., Ianiro, G., de Paulis, A., Spadaro, G., Marone, G., Gasbarrini, A., & Varricchi, G. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01006-3 · Cited by 18
“Administration of A. muciniphila can help protect against certain metabolic diseases [169–172] and inflammatory disorders [173, 174], influence gut permeability [175], and promote the response to cancer immuno-therapy [176] in mouse models.”
BackgroundBovine Milk Derived Exosomes Affect Gut Microbiota of DSS-Induced Colitis Mice
Li, T., Chen, X., Liu, Y., Hua, R., Qi, Q., & Feng, X. L. (2024) · Indian Journal of Microbiology · doi:10.1007/s12088-023-01131-3 · Cited by 16
Wang, X., Wang, P., Li, Y., Guo, H., Wang, R., Liu, S., Qiu, J., Wang, X., Hao, Y., Zhao, Y., et al. (2024) · Engineering · doi:10.1016/j.eng.2023.10.016 · Cited by 16
Seo, H., Kim, S., Beck, S., & Song, H. (2024) · Cells · doi:10.3390/cells13232003 · Cited by 18
Wang, K., Li, X., Huang, K., Wu, H., Tan, M., & Su, W. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159546 · Cited by 23
An Oligosaccharide Rich Diet Increases Akkermansia spp. Bacteria in the Equine Microbiota
Lindenberg, F., Lützhøft, D. O., Krych, Ł., Fielden, J., Kot, W., Frøkiær, H., van Galen, G., Nielsen, D. S., & Hansen, A. K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.666039 · Cited by 15
Long, X., Kim, Y.-G., Pyo, Y., Yi, R., Zhao, X., & Park, K. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13488 · Cited by 13
Nakashima, T., Fujii, K., Seki, T., Aoyama, M., Azuma, A., & Kawasome, H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07131-x · Cited by 13
Lee, S., Jo, E., Lee, E.-Y., & Choi, D. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118955 · Cited by 13
The protective effect of Okanin on Colitis induced by dextran sulfate sodium in mice
Shi, K., Yu, F., Li, A., Wang, Y., & Sun, W. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103527 · Cited by 12
Goryunov, K. V., Ivanov, M., Kulikov, A. V., Shevtsova, Y., Александрович, Б. А., Podurovskaya, Y. L., Zubkov, V. V., Degtyarev, D. N., Sukhikh, G. T., & Silachev, D. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052879 · Cited by 14
“For example, the oral administration of OMVs produced by Akkermansia muciniphila resulted in reduced neutrophil infiltration and the restoration of intestinal barrier integrity in mice with colitis [235,236].”
BackgroundPirolli, N. H., Raufman, J., & Jay, S. M. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf107 · Cited by 15
Targeting the gut to prevent and counteract metabolic disorders and pathologies during aging
Milenković, D., Capel, F., Combaret, L., Comte, B., Dardevet, D. P., Evrard, B., Guillet, C., Monfoulet, L., Pinel, A., Polakof, S., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2089870 · Cited by 16
“In another mouse model of colitis, EVs produced by Akkermansia muciniphila had a protective function that ameliorated the disease severity (Kang et al. 2013).”
Backgroundvan Beek, A. A., Hoogerland, J. A., Belzer, C., de Vos, P., de Vos, W. M., Savelkoul, H. F. J., & Leenen, P. J. M. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0094 · Cited by 12
Pathogenesis Mediated by Bacterial Membrane Vesicles
Gilmore, W. J., Bitto, N. J., & Kaparakis‐Liaskos, M. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_6 · Cited by 14
Xiong, H., Chen, H., Chen, L., Ouyang, K., Lin, S., & Wang, W. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250078 · Cited by 11
The Critical Role of Host and Bacterial Extracellular Vesicles in Endometriosis
Wagner, M., Hicks, C., El-Omar, E. M., Combes, V., & El‐Assaad, F. (2024) · Biomedicines · doi:10.3390/biomedicines12112585 · Cited by 11
Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes
Takeda, Y., Kobayashi, S., Kitakaze, M., Yamada, D., Akita, H., Asai, A., Konno, M., Arai, T., Kitagawa, T., Ofusa, K., et al. (2020) · Cells · doi:10.3390/cells9071645 · Cited by 12
Gut microbiota in Parkinson’s disease patients: hospital-based study
Khedr, E. M., Ali, A. M., Daef, E., Hassan, H. M., Alaa, A., & Gamea, A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00407-z · Cited by 13
“Kang and colleague on their experimentally induced colitis found that the protective effects of extracellular vesicles derived from Akkermansia muciniphila support a beneficial influence on intestinal immunity [23].”
BackgroundSelmi, H., Walker, A., Balas, L., Lucio, M., Klotz, M., Jeridi, A., Burrichter, A. G., Conti, D. E., Chaffringeon, L., Beinsteiner, B., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2601376 · Cited by 11
Zhang, L. H., Ma, Y., Wei, Z., & Li, Q. (2024) · ACS Omega · doi:10.1021/acsomega.4c05961 · Cited by 12
Probiotic membrane vesicles: emerging tools for disease treatment
Verbunt, J., & Stassen, F. R. M. (2025) · Microbiome Research Reports · doi:10.20517/mrr.2025.20 · Cited by 11
Harnessing the small intestinal axis to resolve systemic inflammation
Bodmer, M., Itano, A. A., & McInnes, I. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1060607 · Cited by 10
“Thus oral delivery of EVs of Akkermansia muciniphila was protective in a mouse model of DSS colitis (59) and also able to improve gut permeability with possible benefits in a range of metabolic diseases (60), activities that have been attributed previously to the microbe itself.”
BackgroundGut Microbiome, Obesity, and Metabolic Syndrome
Tilg, H., & Moschen, A. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_26 · Cited by 10
Building better barriers: how nutrition and undernutrition impact pediatric intestinal health
Andres, S. F., Zhang, Y., Kuhn, M. R., & Scottoline, B. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192936 · Cited by 14
Feng, S., Wang, W., Zhang, X., Helal, S. E., Peng, N., & Zhang, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1638771 · Cited by 11
Davies, O., & Rafiq, Q. (2017) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2017.066 · Cited by 10
“In addition to the aforementioned clinical trials, EVs have been applied with successful outcomes in animal models of acute kidney toxicity [16]; neurological disorders such as multiple sclerosis [17] and sciatic nerve injury [18]; and gastrointestinal diseases such as induced colitis [19] and drug-induced inflammator…”
BackgroundBacterial Extracellular Vesicle Composition in Human Urine and the 10-Year Risk of Abdominal Obesity
Shin, C., & Baik, I. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0109 · Cited by 11
“3,9,10 However, data are limited on the association between bacterial EVs assessed in human biospecimens and the health-related outcomes.”
Teng, Y., Li, J., Yan, C., Wang, A., Ren, X., & Xia, X. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104605 · Cited by 9
The worldview of Akkermansia muciniphila, a bibliometric analysis
Zhang, Z., Wang, J., Dang, S., Liu, X., Zhang, Y., & Zhang, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1500893 · Cited by 9
Metadata
- Authors
- Kang, C.-S., Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., Park, S.-K., Jeon, S. G., Roh, T.-Y., Myung, S.-J., Gho, Y. S., Kim, J. G., & Kim, Y.-K.
- Affiliations
- Pohang University of Science and Technology (KR)
- Asan Medical Center (KR)
- Chung-Ang University Healthcare System (KR)
- Corresponding author
- Gho, Yong Song
- Kim, Jae Gyu
- Kim, Yoon-Keun
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-24
- Volume
- 8
- Issue
- 10
- Pages
- e76520
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3811976
- OpenAlex
- W2086465908
- Cited by
- 543
- References
- 36
- Citations by year
- 2026: 33 · 2025: 53 · 2024: 55 · 2023: 67 · 2022: 58 · 2021: 73 · 2020: 58 · 2019: 34 · 2018: 39 · 2017: 30 · 2016: 23 · 2015: 10 · 2014: 10
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- National Research Foundation
- Pohang University of Science and Technology
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea (2011-0000879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- extracellular vesicles, gut microbiota, Akkermansia muciniphila, DSS-induced colitis, inflammatory bowel disease, intestinal inflammation, Bacteroides acidifaciens, interleukin-6, Escherichia coli, intestinal immunity, intestinal homeostasis, commensal bacteria
- MeSH terms
- Animals, Colitis, Disease Models, Animal, Female, Inflammatory Bowel Diseases, Dextran Sulfate, Disease Progression, Secretory Vesicles, Mice, Metagenome, Bacterial Secretion Systems, Verrucomicrobia, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.